Sialyl Tn抗原与宫颈癌淋巴结状态的关联:一项NRG肿瘤学/GOG研究
研究前瞻性收集139例接受淋巴结清扫的局部晚期宫颈癌患者手术标本,其中133例有原发宫颈肿瘤、67例有盆腔淋巴结、28例有腹主动脉旁淋巴结标本,免疫组化检测Tn、STn、MUC1、MUC4。原发肿瘤STn表达高于中位数与盆腔淋巴结阴性状态相关(P=0.0387;OR 0.439,95%CI 0.206-0.935)。作者认为原发宫颈肿瘤STn表达是指导治疗决策和盆腔淋巴结转移机制的候选生物标志物。
要点
- 原发肿瘤STn表达高于中位数与盆腔淋巴结阴性相关(OR 0.439,95%CI 0.206-0.935)。
- 盆腔淋巴结STn表达高于原发肿瘤,原发肿瘤MUC1表达高于腹主动脉旁淋巴结。
- 原发肿瘤MUC4表达高于腹主动脉旁淋巴结或盆腔淋巴结。
核心结论
- 原发宫颈肿瘤STn抗原表达是指导治疗决策和盆腔淋巴结转移机制参与的候选生物标志物。
研究设计与样本
- 前瞻性收集139例接受淋巴结清扫的局部晚期宫颈癌患者手术标本,患者来自一项全国性临床试验(NCT00460356)。
- 其中133例有原发宫颈肿瘤标本,67例有盆腔淋巴结标本,28例有腹主动脉旁淋巴结标本。
- 固定组织连续切片行Tn、STn、MUC1或MUC4免疫组化染色,神经氨酸酶验证Tn与STn抗体特异性。
主要发现
- 原发肿瘤STn表达高于中位数与盆腔淋巴结阴性状态相关(P=0.0387;OR 0.439,95%CI 0.206-0.935)。
- 盆腔淋巴结STn表达高于原发肿瘤(P=0.017)。
- 原发肿瘤MUC1表达高于腹主动脉旁淋巴结(P=0.011)。
- 原发肿瘤MUC4表达高于腹主动脉旁淋巴结(P=0.016)和盆腔淋巴结(P<0.001)。
- Tn与STn表达在原发肿瘤(r=0.301)、腹主动脉旁淋巴结(r=0.686)和盆腔淋巴结(r=0.603)中相关;Tn与MUC1表达仅在原发肿瘤中相关(r=0.249)。
临床怎么用
- 原文结论认为原发宫颈肿瘤STn表达是指导治疗决策的候选生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Detection of lymph node metastases in cervical cancer patients is important for guiding treatment decisions, however accuracies of current detection methods are limited. We evaluated associations of abnormal glycosylation, represented by Tn and STn antigens on mucin (MUC) proteins, in primary tumor specimens with lymph node metastasis or recurrence of cervical cancer patients. METHODS: Surgical specimens were prospectively collected from 139 patients with locally-advanced cervical cancer undergoing lymphadenectomy enrolled in a nation-wide clinical trial (NCT00460356). Of these patients, 133 had primary cervix tumor, 67 had pelvic lymph node (PLN) and 28 had para-aortic lymph node (PALN) specimens. Fixed tissue serial sections were immunohistochemically stained for Tn, STn, MUC1 or MUC4. Neuraminidase was used to validate Tn versus STn antibody specificity. Stain scores were compared with clinical characteristics. RESULTS: Primary tumor STn expression above the median was associated with negative PLN status (p-value: 0.0387; odds ratio 0.439, 95% CI: 0.206 to 0.935). PLN had higher STn compared to primary tumor, while primary tumor had higher MUC1 compared to PALN, and MUC4 compared to PALN or PLN (p = 0.017, p = 0.011, p = 0.016 and p < 0.001, respectively). Tn and STn expression correlated in primary tumor, PALN, and PLN, Tn and MUC1 expression correlated in primary tumors only (Spearman correlation coefficient [r] = 0.301, r = 0.686, r = 0.603 and r = 0.249, respectively). CONCLUSIONS: STn antigen expression in primary cervical tumors is a candidate biomarker for guiding treatment decisions and for mechanistic involvement in PLN metastases.
引用
- Benbrook DM, Deng W, Gold MA, et al. Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study. Gynecol Oncol. 2023. PMID: 36827840. doi:10.1016/j.ygyno.2023.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。